On March 14, 2022, House Rx, a health technology platform focused on improving affordability and patient access to specialty medications, announced it has secured $25 million in Series A financing led by Bessemer Venture Partners, bringing the company’s total funding to $30 million. First Round Capital, Character.vc, and 1984.vc also participated in the Series A funding. First Round Capital led the SAFE seed round as the initial investor alongside Khosla Ventures, Maverick Ventures, and 1984.vc. The proceeds from this latest round will go toward continued investments in House Rx's technology platform and scaling pharmacy operations. Wilson Sonsini Goodrich & Rosati advised House Rx on the transaction.

The Wilson Sonsini team that advised House Rx included Megan Baier and McKenna Pruitt.

For more information, please see House Rx's press release.